三种针对多发性骨髓瘤的BCMA向疗法的特征和利用方法
Keichiro Mihara1,2, Takahiko Miyama3
1International Center for Cell and Gene Therapy, Fujita Health University, 1-98 Dengakugakubo, Kutsukake-Cho, Toyoake, Aichi, 470-1192, Japan. keichiro.mihara@fujita-hu.ac.jp.
International journal of hematology
|December 15, 2025
概括
针对B细胞成熟抗原 (BCMA) 的三种新疗法在多发性骨髓瘤治疗方面表现有前途. 仔细选择患者和治疗顺序对于优化CAR-T,双特异性抗体和抗体与药物合物的结果至关重要.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 药理学 药理学是指药理学的学科.
背景情况:
- 多发性骨髓瘤治疗已经通过新的治疗策略取得了进展.
- B细胞成熟抗原 (BCMA) 是一个关键的目标,因为它的髓瘤细胞特异性表达.
- 以BCMA为向的疗法提供了改善的结果与可管理的毒性.
研究的目的:
- 审查和比较三种针对多发性骨髓瘤的BCMA向疗法:CAR-T细胞疗法,双特异性抗体 (BsAbs) 和抗体-药物联合体 (ADCs).
- 分析这些新型药物的疗效,安全性和治疗序列.
- 突出BCMA表达评估和T细胞耗尽评估的重要性.
主要方法:
- 关于BCMA向治疗的当前文献的综述.
- 对CAR-T (ide-cel,cilta-cel),BsAbs (teclistamab,elranatamab) 和ADCs (belantamab mafodotin) 的临床试验数据进行比较分析.
- 评估反应率,持久性,不良事件和治疗顺序的考虑.
主要成果:
- 卡特-T疗法表现出不同的疗效和耐久性,具有长期缓解的潜力.
- BsAbs提供现成的选择,但可能会导致T细胞耗尽.
- ADCs带来了独特的挑战,包括眼睛毒性.
- 治疗顺序显著影响后续治疗的有效性.
结论:
- 针对BCMA的向疗法代表了多发性骨髓瘤治疗的重大进步.
- 考虑BCMA表达和T细胞状态的个性化治疗策略是必不可少的.
- 优化治疗方案和治疗顺序对于最大限度地使患者受益至关重要.
更多相关视频
相关概念视频
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Combination Therapies and Personalized Medicine
5.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K


